论文部分内容阅读
慢性肝性脑病(HE)以神经精神症状为特征,常可发生于肝硬化和门-体分流患者。已证实乳果糖预防HE效果良好,而拉替妥(乳山糖,lactitol)是一种类似于乳果糖的非吸收性双糖。本文研究肝硬化门体分流患者用拉替妥预防HE的有效性和安全性。
Chronic hepatic encephalopathy (HE) is characterized by neuropsychiatric symptoms and can often occur in patients with cirrhosis and portal-to-body shunting. Lactulose has proven to be effective in preventing HE, while lactitol is a nonabsorbable disaccharide similar to lactulose. This article studies the efficacy and safety of raltitol in patients with cirrhosis and portosystemic shunt.